Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia Ulrika Palmer-Kazen, MD, David.

Slides:

Advertisements

Similar presentations

Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans Per Örtenwall, MD, PhD *, Hans Wadenvik, MD, PhD **, Jack Kutti, MD, PhD **,

Advertisements

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:

Jeremy D. Kauffman, MD, T. Joseph Watson, MD, Joseph J. Campbell, MD

S. Sulaiman Shoab, MD, FCPS, FRCS, J. H. Scurr, MS, FRCS, P. D

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro.

Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia Jayer Chung, MD, J. Gregory Modrall, MD, Chul.

Without prejudice Journal of Vascular Surgery

Ultrasound measurement of the luminal diameter of the abdominal aorta and iliac arteries in patients without vascular disease Ole Martin Pedersen, MD,

Outcomes of endovascular lower extremity interventions depend more on indication than physician specialty Justin R. Wallace, MD, MSc, Theodore Yuo, MD,

Monica S. O'Brien-Irr, MS, RN, Hasan H. Dosluoglu, MD, Linda M

Robert J. Beaulieu, MD, K. Dean Arnaoutakis, MD, Christopher J

Society for Vascular Surgery® (SVS)—The beginning

Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia Louis L. Nguyen,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Smoking cessation is associated with decreased mortality and improved amputation- free survival among patients with symptomatic peripheral artery disease

Neal R. Barshes, MD, MPH, James D

Jayer Chung, MD, David A. Timaran, MD, J

Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010 Grant H. Skrepnek, PhD, David G. Armstrong,

Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation Thomas M. Loh,

Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr

Overexpression of transforming growth factor–β1 correlates with increased synthesis of nitric oxide synthase in varicose veins Theresa Jacob, PhD, Anil.

Mohamed A. Zayed, MD, PhD, Ronald L. Dalman, MD, Jason T. Lee, MD

A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences Birgitta Sigvant,

Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease Alessandra Bitto, MD, Francesca Polito,

Fibronectin promotes VEGF-induced CD34+ cell differentiation into endothelial cells Errol S Wijelath, PhD, Salman Rahman, PhD, Jacqueline Murray, PhD,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

The first operation on the profunda femoris artery

PC152. Risk Associated With Female Gender for More Advanced Peripheral Arterial Disease at Time of Femoropopliteal Bypass Remains Constant from 2003 to.

Without prejudice Journal of Vascular Surgery

Michael S. Conte, MD Journal of Vascular Surgery

Insulin use is associated with poor limb salvage and survival in diabetic patients with chronic limb ischemia Hasan H. Dosluoglu, MD, Purandath Lall,

Infected aneurysm of the thoracic aorta

Changing demographics in patients with vascular disease

Clinical and economic evaluation of the trellis thrombectomy device for arterial occlusions: preliminary analysis Timur P. Sarac, MD, Daniel Hilleman,

Alexis Carrel's historic leap of faith

Jeremy D. Kauffman, MD, T. Joseph Watson, MD, Joseph J. Campbell, MD

The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia Mohammad.

Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England Meghan Dermody, MD, MS, Christopher Homsy, MD, Yuanyuan.

Shadi J. Abu-Halimah Journal of Vascular Surgery

The natural history of untreated severe or critical limb ischemia

Outcomes of reinterventions after subintimal angioplasty

Jayer Chung, MD, J. Gregory Modrall, MD, R. James Valentine, MD

Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques Benjamin J. Dunmore, PhD, Mark J. McCarthy,

The Use of Micro-Oxygen Sensors (MOXYs) to Determine Dynamic Relative Oxygen Indices in the Foot of Patients with Critical Limb Ischemia (CLI) During.

Todd R. Vogel, MD, MPH, Gregory F. Petroski, PhD, Robin L. Kruse, PhD

Completion duplex ultrasound predicts early graft thrombosis after crural bypass in patients with critical limb ischemia Salvatore T. Scali, MD, Adam.

Reply Journal of Vascular Surgery

Ramyar Gilani, MD, Roy K. Greenberg, MD, Douglas R. Johnston, MD

Reviewer Acknowledgment

Thrombotic mesenteric ischemia due to aortic dissection

Vascular endothelial growth factor in patients with acute asthma

David L. Dawson, MD, Jennifer Meyer, RCIS, Eugene S

Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage Andrea E. Yancey, MD, David J. Minion,

Manish Mehta, MD, MPH, Yi Zhou, MD, Philip S. K

Angiogenesis and arteriogenesis in limb ischemia

Activated protein C-protein C inhibitor complex: A new biological marker for aortic aneurysms Tilo Kölbel, MD, Karin Strandberg, MD, PhD, Ingrid Mattiasson,

Using the diamond intermediate anastomosis in composite sequential bypass grafting for critical limb ischemia Ailín C. Rogers, PhD, Paul W. Reddy, MBBCh.

Regarding “Lunar cycles and abdominal aortic aneurysm rupture”

Ignacio Hernández-Lahoz, MD, Raul Garcia-Casas, MD

Long-term prognostic factors after thrombolysis for lower limb ischemia Monica Kuoppala, MD, Sofia Franzén, MD, Bengt Lindblad, MD, PhD, Stefan Acosta,

Resource utilization in the treatment of critical limb ischemia: the effect of tissue loss, comorbidities, and graft-related events Louis L. Nguyen,

Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers Susan L Drinkwater, BSc, Kevin G Burnand, MS, Ren Ding, PhD, Alberto Smith,

Ioannis Prionidis, MD, Tom F. Browne Journal of Vascular Surgery

The effects of endothelial injury on smooth muscle cell proliferation

Bhagwan Satiani, MD, MBA, Thomas E. Williams, MD, PhD, Michael R

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Prognosis of critical limb ischemia patients with tissue loss after achievement of complete wound healing by endovascular therapy Norihiro Kobayashi,

True Radial Artery Aneurysm: Diagnosis and Treatment

Unusual aortic collapse in acute mesenteric ischemia

Results of a single center vascular screening and education program

Presentation transcript:

Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia Ulrika Palmer-Kazen, MD, David Wariaro, Fuwen Luo, MD, Eric Wahlberg, MD, PhD Journal of Vascular Surgery Volume 39, Issue 3, Pages 621-628 (March 2004) DOI: 10.1016/j.jvs.2003.07.006

Fig 1 Examples of individual growth factor concentrations in tissue samples from 25 patients with critical limb ischemia. Skin concentrations of VEGF (A) and muscle concentrations of FGF-2 (B) (proximal samples are missing in two of the patients). Journal of Vascular Surgery 2004 39, 621-628DOI: (10.1016/j.jvs.2003.07.006)

Fig 2 Mean (SD) concentrations of VEGF and FGF-2 in patient and control samples Journal of Vascular Surgery 2004 39, 621-628DOI: (10.1016/j.jvs.2003.07.006)

Fig 3 Staining (brown) of distal samples from one patient with CLI (patient 11). A, Negative control skin; B, anti-VEGF skin; C, anti–FGF-2 skin; D, negative control muscle; E, anti-VEGF muscle; and F, anti–FGF-2 muscle. Journal of Vascular Surgery 2004 39, 621-628DOI: (10.1016/j.jvs.2003.07.006)